Stock Research: Ebos

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Ebos

NZC:EBO NZEBOE0001S6
44
  • Value
    95
  • Growth
    9
  • Safety
    Safety
    44
  • Combined
    46
  • Sentiment
    43
  • 360° View
    360° View
    44
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

EBOS Group Limited is a marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products, and animal care brands. It operates in the Healthcare and Animal Care industries and includes brands such as Symbion, ProPharma, and TerryWhite Chemmart. It operates in Australia and New Zealand. In the last fiscal year, the company had a market cap of $4,833 million, profits of $1,089 million, revenue of $8,793 million, and 5200 employees.

more
Index
ASX 200
ASX 300
NZSX 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
95 11 16 15
Growth
9 43 3 91
Safety
Safety
44 39 55 55
Sentiment
43 65 62 82
360° View
360° View
44 22 12 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
44 53 34 49
Opinions Change
63 68 21 50
Pro Holdings
n/a 27 82 60
Market Pulse
49 81 76 85
Sentiment
43 65 62 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
95 11 16 15
Growth
9 43 3 91
Safety Safety
44 39 55 55
Combined
46 12 6 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
90 51 66 61
Price vs. Earnings (P/E)
65 17 23 16
Price vs. Book (P/B)
77 14 17 23
Dividend Yield
86 40 48 36
Value
95 11 16 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
50 49 1 61
Profit Growth
41 20 49 31
Capital Growth
52 22 7 87
Stock Returns
1 71 15 87
Growth
9 43 3 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
36 37 48 52
Refinancing
34 10 24 28
Liquidity
61 68 69 62
Safety Safety
44 39 55 55

Similar Stocks

Discover high‑ranked alternatives to Ebos and broaden your portfolio horizons.

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Medium
Full Stock Analysis

Kelsian

ASX:KLS
Country: Australia
Industry: Highways & Railtracks
Size: Medium
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: